<font color="red">Ascaris_1</font> and growth rates : a randomized trial of treatment . 
<br>
<br> <font color="red">Three_2</font> <font color="red">hundred_2</font> <font color="red">forty_2</font> <font color="red">-_2</font> <font color="red">one_2</font> <font color="red">Tanzanian_2</font> <font color="red">preschool_2</font> <font color="red">children_2</font> were randomly assigned to levamisole or placebo treatment given at three - month intervals . Weights and heights were measured at the tri - monthly treatment visits for a period of one year . Among the <font color="red">273_1</font> <font color="red">children_1</font> <font color="red">who_1</font> <font color="red">were_1</font> <font color="red">seen_1</font> <font color="red">and_1</font> <font color="red">weighed_1</font> <font color="red">at_1</font> <font color="red">the_1</font> <font color="red">one_1</font> <font color="red">-_1</font> <font color="red">year_1</font> <font color="red">follow_1</font> <font color="red">-_1</font> <font color="red">up_1</font> <font color="red">visit_1</font> <font color="red">,_1</font> the rate of weight gain was 8 per cent greater for those receiving levamisole than for placebo - treated controls ( p = .06 ) . In 78 children known to be infected with <font color="red">Ascaris_1</font> at baseline , the rate of weight gain was 21 per cent greater in children treated with levamisole than in those receiving placebo ( p = .03 ) . The rate of height gain was no different for treatment and placebo groups .